• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

USPSTF Issues Draft Statement on Low-dose Aspirin to Prevent CVD, Cancer
On Sept. 15, the U.S. Preventive Services Task Force posted a draft recommendation statement supporting prophylactic low-dose aspirin therapy for patients ages 50-59 who have an increased risk of heart attack and stroke.
Source: AAFP News - September 16, 2015 Category: Primary Care Source Type: news

Panel recommends daily aspirin to prevent heart attack, colorectal cancer
Stephen FellerROCKVILLE, Md., Sept. 15 (UPI) -- A government task force suggests people between age 50 and 69 take aspirin every day to help prevent heart attack, stroke and colorectal cancer.
Source: Health News - UPI.com - September 15, 2015 Category: Consumer Health News Source Type: news

An aspirin a day helps prevent heart attack, stroke and colon cancer
A daily aspirin should be given to 50-year-olds at risk of suffering a heart attack or stroke in the next decade as long as they are not at risk of bleeding, the US Preventive Services Task Force said.
Source: the Mail online | Health - September 15, 2015 Category: Consumer Health News Source Type: news

Aspirin and Your Health
Source: HealthDay - Related MedlinePlus Pages: Blood Thinners, Colorectal Cancer, Heart Attack, Stroke
Source: MedlinePlus Health News - September 15, 2015 Category: Consumer Health News Source Type: news

Medical News Today: Adults in their 50s should take aspirin daily for heart attack, stroke prevention
The USPSTF say adults aged 50-59 should take aspirin daily to prevent first stroke or heart attack, while taking the drug for at least 10 years may lower colorectal cancer risk.
Source: Health News from Medical News Today - September 15, 2015 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Low-Dose Aspirin Recommended at Ages 50 to 69
An influential federal panel recommended daily low-dose aspirin for men and women ages 50 to 69 to prevent heart attacks, stroke and colorectal cancer, setting off what is expected to be an intense debate given the drug’s side effects, including higher risk of bleeding.
Source: WSJ.com: Health - September 15, 2015 Category: Pharmaceuticals Tags: FREE Source Type: news

Hidden cancer rarely causes out-of-the-blue clots in the bloodstream
Blood clots can be lifesavers when they form outside the bloodstream to stop bleeding from an injury. But they can wreak havoc when they form inside the bloodstream. A blood clot in a coronary artery can cause a heart attack. One in the brain can cause a stroke. Blood clots that form in a leg vein cause a problem known as venous thromboembolism, or VTE. If the clot stays in the leg, it can cause swelling or pain. If it breaks away and travels to the lungs, it can cause a potentially deadly pulmonary embolism. In about half of people who develop a VTE, doctors can identify what caused it. Common causes include an injury; su...
Source: New Harvard Health Information - June 29, 2015 Category: Consumer Health News Authors: Howard LeWine, M.D. Tags: Cancer blood clot venous thromboembolism VTE Source Type: news

From Bermuda to Boston for surgery to protect the brain of a boy with sickle cell disease
Calvin Steede, who lives in Bermuda, will never forget the day in 2011 when he saw the movie “Winnie the Pooh” with his mother and sister. The film ended, and suddenly the boy who likes to draw and play soccer couldn’t put on his backpack. His arms had stopped working. He couldn’t stand, and soon he couldn’t talk. Calvin, now 11, had suffered a minor stroke, a complication of sickle cell disease and the first step of a journey that would take him to Dana-Farber/Boston Children’s Cancer and Blood Disorders Center for minimally invasive surgery to protect his brain from future strokes. Sickle cell disease Sickle ...
Source: Thrive, Children's Hospital Boston - June 19, 2015 Category: Pediatrics Authors: Irene Sege Tags: Diseases & conditions Dana-Farber/Boston Children's Cancer and Blood Disorders Center moyamoya sickle cell disease Source Type: news

Carotid Intima‐Media Thickness Measurement Promises to Improve Cardiovascular Risk Evaluation in Head and Neck Cancer Patients
ConclusionsCarotid IMT identified a much greater percentage of radiation‐treated HNC patients at high CV risk compared with standard CV‐risk calculators. By more accurately identifying the patients at high risk, this may lead to more effective prevention, and therefore a reduction in CV events.
Source: Clinical Cardiology - May 11, 2015 Category: Cardiology Authors: Douglas Jacoby, Jihane Hajj, Ali Javaheri, Emil deGoma, Alexander Lin, Peter Ahn, Harry Quon Tags: Clinical Investigations Source Type: research

Aspirin in the perioperative period: a review of the recent literature
Purpose of review: The indications for aspirin (ASA) for both primary and secondary prevention of thrombotic events continue to evolve. We review some of these indications and the recent literature regarding the perioperative administration of ASA. Recent findings: ASA for primary prevention of cardiac ischemia, stroke, cancer, and death remains controversial. When used for primary prevention, ASA may be safely discontinued perioperatively. Patients with coronary or carotid artery stents should continue to receive ASA perioperatively. For patients with ischemic heart disease currently receiving ASA for secondary prevention...
Source: Current Opinion in Anaesthesiology - May 1, 2015 Category: Anesthesiology Tags: ANESTHESIA AND MEDICAL DISEASE: Edited by Natalie F. Holt Source Type: research

Survey shows half of older adults in US now taking aspirin
(Oregon State University) A national survey suggests that slightly more than half of the older adults in the United States are now taking a daily dose of aspirin, even though its use is not recommended by the Food and Drug Administration for most people who have not yet had a heart attack or stroke. The findings suggest that tens of millions of Americans have reviewed the issues involved, often discussed it with their doctors, say they know what they are doing -- and decided to use aspirin.
Source: EurekAlert! - Cancer - April 16, 2015 Category: Cancer & Oncology Source Type: news

An Aspirin a Day: Is the Benefit Worth the Risk?
Studies have shown that aspirin, the age old remedy for pain and fever, also thins the blood. Because of this property, it can also help to lower the chances of a heart attack or a stroke caused by a blood clot in the brain. And, although research has found that it only works in certain people (specifically, those with a history of heart attack or stroke) many Americans are inappropriately taking daily, low doses of aspirin as a preventative measure. In fact, researchers have found that about 12 percent of the of nearly 69,000 U.S. adults taking aspirin on a long-term basis should not have received the prescription in the ...
Source: Healthy Living - The Huffington Post - March 13, 2015 Category: Consumer Health News Source Type: news

Nanoparticles used to treat damaged arteries
Conclusion This exciting study in mice has shown that nanoparticles can be manufactured to target the plaques that form in atherosclerosis, and help stabilise them. It appears that the nanoparticles honed in on the plaques, rather than affecting other organs such as the spleen or liver, which gives an early indication that there may not be substantial side effects. However, it will be necessary to see if the same holds true for other organs. As with all mice studies, they give an indication of the likely biological effects of a new technique, but they do not provide the full picture of what may happen in humans, especially...
Source: NHS News Feed - February 19, 2015 Category: Consumer Health News Tags: Heart/lungs Medical practice Medication Source Type: news

Management of hemichorea hemiballismus syndrome in an acute palliative care setting
We describe a case of HCHB presenting to a palliative care setting. A 63-year-old diabetic and hypertensive lady, with history of ovarian cancer presented to Palliative Medicine outpatient clinic with two days history of right HCHB. Blood investigations and brain imaging showed high blood sugar levels and lacunar subcortical stroke. Blood sugar levels were controlled with human insulin and Aspirin. Clopidogrel and Atorvastatin were prescribed for the management of lacunar stroke. HCHB reduced markedly post-treatment, leading to significant reduction in morbidity and improvement in quality of life. The symptoms completely r...
Source: Indian Journal of Palliative Care - January 28, 2015 Category: Palliative Care Authors: Anuja DamaniArunangshu GhoshalNaveen SalinsJayita DeodharMary Ann Muckaden Source Type: research

Wholegrains, not just porridge, may increase life
Conclusion This analysis of two large prospective cohort studies from the US has found an association between higher wholegrain intake and a reduced risk of death during follow-up, particularly from heart disease. The study benefits from its large size (more than 100,000 participants) and long duration, as well as the thorough collection of information on the participants as the study progressed (prospective data collection). Our diets and lifestyles are very complex, and it is very difficult to entirely isolate the effect of one dietary component and remove the effect of all other factors. However, the researchers have ...
Source: NHS News Feed - January 6, 2015 Category: Consumer Health News Tags: Heart/lungs Food/diet Source Type: news

Pages: 1  2  3  4  5  6  7  8